Focus on FAPI Newsletter – Summer 2024

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI […]

2024-09-04T21:12:40+00:00September 4th, 2024|Newsletter|

99mTc-HFAPi SPECT imaging predicts left ventricular remodeling after acute myocardial infarction

Cuncun Hua, Xiao-Ying Xi, Yeping Zhang, Ni Suo, Bin Tu, Ye Liu, Xiaoyan Yang, Xiaoyan […]

2024-09-04T14:26:34+00:00August 4th, 2024|Publications|

Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel […]

2024-09-04T13:55:53+00:00August 1st, 2024|Publications|

SOFIE and GE HealthCare SNMMI Symposium highlights FAP targeting

June 9, 2024 (Toronto, CA) –  SNMMI annual meeting attendees had the opportunity to learn […]

2024-07-30T19:58:41+00:00June 12th, 2024|News|

Trilantic North America Completes Strategic Growth Investment in SOFIE Biosciences

NEW YORK (June 4, 2024) – Trilantic North America, a growth-focused middle market private equity […]

2024-06-04T13:06:13+00:00June 4th, 2024|News|

Focus on FAPI Newsletter – Spring 2024

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI […]

2024-06-03T20:44:44+00:00June 3rd, 2024|Newsletter|

The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review

Domenico Albano, Alessio Rizzo, Riemer H J A Slart, Søren Hess, Edel Noriega-Álvarez, Cristina Gamila […]

2024-09-04T13:59:05+00:00May 31st, 2024|Publications|

[18F]FAPI-74 serving as complementary diagnostic in Avacta Phase 1 trial

May 23, 2024 – SOFIE is pleased to partner with Avacta through Avacta’s use […]

2024-06-03T20:17:45+00:00May 23rd, 2024|News|

[68Ga]Ga-FAPI-46 PET/CT for penile cancer – a feasibility study

Lennert Eismann, Stephan T Ledderose, Benazir Enzinger, Elena Berg, Thilo Westhofen, Severin Rodler, Gerald B […]

2024-06-03T17:14:58+00:00May 18th, 2024|Publications|

68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy

Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, Mélanie Desaulniers, Marc Ingenwerth, Nader Hirmas, Lukas […]

2024-06-03T18:27:17+00:00May 9th, 2024|Publications|
Go to Top